GlassScriptPhysician profile
Mary P Gallagher
NPI 1730550989
$229,234.43
in general payments reported to CMS, 2019-2025
7 companies · $54K in 2025
The $54K reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $42K · 2022: $64K · 2023: $21K · 2024: $49K · 2025: $54K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $115K · Travel and Lodging: $5,201 · Food and Beverage: $2,813 · Education: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $115,339.18 |
| Travel and Lodging | $5,200.85 |
| Food and Beverage | $2,812.90 |
| Education | $149.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $123,312.82 | 2021-2025 | |
| Allergan, INC. | $105,559.19 | 2021-2022 | |
| Janssen Biotech, INC. | $116.20 | 2021 | |
| Incyte Corporation | $114.99 | 2022-2023 | |
| Revance Therapeutics, INC. | $98.50 | 2025 | Daxxify |
| Janssen Pharmaceuticals, INC | $20.74 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $11.99 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Gallagher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.